4//SEC Filing
FINKELSTEIN J J 4
Accession 0001437749-22-013083
CIK 0000707511other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:03 PM ET
Size
24.3 KB
Accession
0001437749-22-013083
Insider Transaction Report
Form 4
FINKELSTEIN J J
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-05-17+600,000→ 600,000 totalExercise: $0.19Exp: 2032-05-17→ Common Stock (600,000 underlying)
Holdings
- 1,712,991
Common Stock
- 500,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (500,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (200,000 underlying) - 150,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (150,000 underlying) - 250,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (250,000 underlying) - 650,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2029-05-15→ Common Stock (650,000 underlying) - 500,000
Stock Option (right to buy)
Exercise: $0.30Exp: 2030-06-10→ Common Stock (500,000 underlying) - 78,125
Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (104,167 underlying) - 78,125
Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-05-13Exp: 2024-05-13→ Common Stock (104,167 underlying) - 20,880
Convertible Promissory Note (right to buy)
Exercise: $0.36From: 2020-10-15Exp: 2025-10-15→ Common Stock (27,840 underlying) - 56,250
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (78,125 underlying) - 56,250
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-11-13Exp: 2024-05-13→ Common Stock (78,125 underlying) - 0
Common Stock Warrant (right to buy)
Exercise: $0.45From: 2021-04-15Exp: 2025-10-15→ Common Stock (20,880 underlying) - 0
Series A Common Stock Warrant (right to buy)
Exercise: $0.24From: 2021-06-30Exp: 2023-06-30→ Common Stock (56,250 underlying) - 0
Series B Common Stock Warrant (right to buy)
Exercise: $0.28From: 2021-06-30Exp: 2026-06-30→ Common Stock (56,250 underlying) - 600,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2031-08-02→ Common Stock (600,000 underlying)
Footnotes (4)
- [F1]100% vested.
- [F2]125,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
- [F3]150,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24.
- [F4]150,000 shares vest on each of 5/17/22, 5/17/23, 5/17/24 and 5/17/25.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001125610
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:03 PM ET
- Size
- 24.3 KB